Related Experiment Video
Updated: Mar 16, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
6.1K
Ubc13: the Lys63 ubiquitin chain building machine
Curtis D Hodge1, Leo Spyracopoulos1, J N Mark Glover1
1Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Oncotarget
|August 4, 2016
Summary
Ubc13, an E2 enzyme, forms critical Lys63 ubiquitin chains for cellular signaling. This review explores Ubc13
Area of Science:
- Biochemistry and Molecular Biology
- Cellular Signaling
- Drug Discovery
Background:
- Ubc13 is an E2 ubiquitin conjugating enzyme essential for forming lysine 63-linked (Lys63) ubiquitin chains.
- Lys63 ubiquitin chains are crucial signaling molecules in inflammatory and DNA damage response pathways.
- Ubc13 is implicated as a therapeutic target for cancers, drug resistance, inflammation, and viral infections.
Purpose of the Study:
- To provide a comprehensive global review of Ubc13.
- To integrate structural and mechanistic insights with Ubc13's biological functions.
- To assess Ubc13 as a potential therapeutic target by examining its inhibition.
Main Methods:
- Literature review of studies implicating Ubc13 in biological functions.
- Analysis of existing structural data for Ubc13.
- Discussion of natural and chemical inhibition of Ubc13.
Main Results:
- Ubc13 participates with various E3 ligases to generate Lys63 ubiquitin chains.
- Multiple Ubc13 structures reveal a novel activation mechanism involving active site loop conformational changes.
- Ubc13's role in critical cellular pathways highlights its therapeutic potential.
Conclusions:
- Ubc13 is a key enzyme in ubiquitin-dependent signaling pathways.
- Structural insights suggest a unique mechanism for Ubc13 activation.
- Further understanding of Ubc13 is vital for developing targeted therapies for diseases like cancer and chronic inflammation.
Related Concept Videos
The Proteasome
1.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
Regulated Protein Degradation
9.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.1K
Covalently Linked Protein Regulators
9.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.9K
Protein Complexes with Interchangeable Parts
3.0K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K
Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K

